HB1166
To Clarify The Types Of Epinephrine For Use In Elementary And Secondary Schools In This State.
AI-Generated Summary
This bill, known as "Alex's Law," aims to clarify the types of epinephrine that can be used in Arkansas elementary and secondary schools. It defines "epinephrine" to include only auto-injectable epinephrine and epinephrine nasal spray that have received FDA approval for anaphylaxis treatment. The law outlines procedures for students to carry and self-administer asthma inhalers or auto-injectable epinephrine. This includes requirements for written authorization from parents or guardians, valid medical documentation, and a demonstration of skill in using the medication. The bill also addresses the provision of medication by parents if a student does not carry their own. Furthermore, it clarifies that school districts, employees, and agents are generally not liable for injuries resulting from a student's use or self-administration of prescribed medication. It also provides immunity to school entities and personnel for good-faith administration of epinephrine auto-injectors or albuterol in emergency situations, with an exception for intentional or willful misconduct. The bill requires schools to adopt policies for the provision and administration of these medications and outlines certification requirements for school personnel trained in their administration.
Potential Impact Analysis
Who Might Benefit?
Primary beneficiaries of this bill would be students in Arkansas elementary and secondary schools who have asthma or are at risk of anaphylaxis. Parents and guardians of these students would also benefit from clearer guidelines on how their children can access and use necessary medications at school. School nurses and trained school employees would benefit from clarified protocols and protections related to administering epinephrine and albuterol in emergencies. School districts and public charter schools would benefit from defined liability protections and the ability to acquire and stock essential medications.
Who Might Suffer?
Potential negative impacts are less direct and more systemic. Some school districts or individual schools might face administrative burdens or costs associated with developing and implementing the required policies and training for staff. There is also a potential for increased liability or scrutiny if errors in good-faith administration occur, despite the provided immunity. Families who cannot afford or obtain the necessary prescriptions or medical documentation for their children may be negatively impacted if they cannot meet the requirements for their child to self-carry or have medication available at school.